AIIMS researchers claim to have made significant progress in developing chimeric antigen receptor (CAR) T-cell therapy, ...

AIIMS Delhi has achieved a groundbreaking milestone in cancer treatment by developing an antibody-based therapy for recurrent cancers, specifically M ...

Africa's low COVID-19 mortality rates concealed important vulnerabilities, including poor health infrastructure and manufacturing constraints,1 highlighting the need for a proactive, continent-wide ...

Manufacturing practices are evolving to advance antibody drug conjugates (ADCs) for cancer treatment through a targeted approach.

Structural Genomics Consortium researchers at The Neuro (Montreal Neurological Institute-Hospital) of McGill University, in ...

For the latest information on the expiration dates for your COVID-19 test kits, be sure to check the FDA's At-Home OTC ...

Amgen's leukemia drug Blincyto infringes patents owned by Germany's Lindis Biotech, a Delaware federal jury said in a verdict ...

Sun, Y. , Cheng, X. and Pen, K. (2024) Clinical Value of Platelet-Related Parameters and Monocyte Counts in Patients with ...

To generate polyclonal antibodies, laboratory animals are injected with the antigen of interest and, in a few weeks (with luck), one obtains antibodies that recognize the antigen with high ...